x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization. Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist

science life sciences

All Episodes

41:04

Leading M&A at a top-5 global CDMO

Molecule to Market: Inside the outsourcing space ·

2020/11/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mark Quick, Executive Vice President, Corporate Development at Recipharm. In the decade that Mark and Raman have known each other, Mark has risen from a BD role in a small Swedish CMO, to becoming one of the key leaders in a business that has transitioned into becoming one of the top global CDMOs, where Mark has spearheaded the M&A deals. A graduate in Industrial Studies, Mark

en

48:27

The virotherapy virtuoso

Molecule to Market: Inside the outsourcing space ·

2020/11/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Stefan Beyer, President and Managing Director at Vibalogics and Tom Hochuli, Chief Executive Officer at Vibalogics. Who is this dynamic duo you ask? Stefan has spent the bulk of his career in the vaccines and biologics space. He has been head of Vibalogics for almost 13 years, steering the company from a local startup, to global CDMO and world leader in the production of

en

01:08:51

Roundtable: Collaboration and driving efficiency

Molecule to Market: Inside the outsourcing space ·

2020/10/16

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Dexter Tjoa, Chief Executive Officer at Tjoapack, Erik Haeffler, VP Manufacturing Services & Head of Sustainability at Recipharm AB, John Ross, President at Mayne Pharma and Metrics Contract Services, and Mark Emalfarb, CEO, Board Member and Founder at Dyadic

en

01:03:35

Roundtable: Latest trends in CDMO

Molecule to Market: Inside the outsourcing space ·

2020/10/15

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Roger Lias Chief Executive Officer at Stelis Biopharma Pvt. Ltd. and Stelis Biopharma LLC, Mark Quick, Executive Vice President Corporate Development at Recipharm AB, Lynn Allen, Vice President Of Business Development at MedPharm Ltd, Alfredo Gomez, Head of Site

en

53:22

Roundtable: Clinical trials in 2020 and beyond

Molecule to Market: Inside the outsourcing space ·

2020/10/15

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Torkel Gren, Senior Director, Technology Officer & Strategic Investments at Recipharm, Sascha Sonnenberg, Global Head of Business Development at Sharp Clinical Services, Vincent Dunne, CEO at Wasdell Group and Stephen Rode, Business Development Manager for Lonza

en

01:02:01

Roundtable: Global geography and the pharma and bio...

Molecule to Market: Inside the outsourcing space ·

2020/10/13

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Erik Haeffler, VP Manufacturing Services & Head of Sustainability at Recipharm AB, Dan Stanton, Founder and Editor of Bioprocess Insider and Stefano Console, Senior Advisor and Founder at Oriento. Join us as we discuss the impact of COVID-19 on the pharma and bio

en

43:29

Scientist & champion powerlifter

Molecule to Market: Inside the outsourcing space ·

2020/09/29

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Shane Needham, Chief Founding Scientist, Director of the Board and Owner at Alturas Analytics, Inc. With a PHD in chemistry, Dr. Needham has spent almost 30 years in the sector. He started his career at Pfizer and went on to found his own company, Alturas Analytics, which focuses on solving complex bioanalytical problems. He has over 100 publications and external presentations in

en

46:25

From fax to SaaS: digitising the the pharma supply chain

Molecule to Market: Inside the outsourcing space ·

2020/09/22

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason Lacombe, CEO at Veratrak. A graduate of Toronto and Oxford University, Jason was recently named as one of Forbes 30 Under 30 and has also advised the WHO and EU. Today, his business is one of the fastest growing tech companies in the life science space. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jason, covering the impact

en

49:35

Successful outsourcing partnerships: now and then

Molecule to Market: Inside the outsourcing space ·

2020/09/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mary Christian, Senior Vice President, Regulatory at Lyndra Therapeutics. To say Mary has an impressive track record is an understatement. Across the last three decades she has worked for some of the biggest pharmaceutical companies in the world including Janssen and Bristol Myers Squibb before moving onto several fast growing biotech companies including Ironwood, Cyclerion and

en

40:55

Old world solutions won’t work for new world problems

Molecule to Market: Inside the outsourcing space ·

2020/08/31

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sara Lesina, Global Marketing Director of Pharma & Nutrition, Capsules and Health Ingredients at Lonza. A multilingual, international marketing leader, Sara oversees the global marketing and product line management team for the capsule business of Lonza, Capsugel®. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guest Sara Lesina, covering

en

38:28

Looking towards the future: A continuous mindset

Molecule to Market: Inside the outsourcing space ·

2020/08/25

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Carl-Åke Carlsson CEO at Xellia Pharmaceuticals. Like celebrated “one-club” football stars like Leo Messi at Barcelona, Alessandro Del Piero at Juventus and Steven Gerrard at Liverpool… Carl-Åke has been with Xellia since 1988. A pharmaceutical leader known for his class and commercial acumen, Carl‑Åke started in a finance position. He was soon diversifying into other areas and

en

32:31

Life in a boutique, specialist CDMO

Molecule to Market: Inside the outsourcing space ·

2020/08/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Manuel Leal, Business Development Director at IDIFARMA. A student of law and business, Manuel has carved a very impressive career in the outsourcing space all despite having no formal pharma and science background! He has spent the last decade helping take a little known, local formulation development firm in Northern Spain into a global, specialist CDMO. Your host, Raman

en

43:36

Owning your authenticity

Molecule to Market: Inside the outsourcing space ·

2020/08/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Thompson, CEO and Founder at Agility Life Sciences. Claire is an award winning pharmaceutical scientist with over 20 years of experience in developing pharma products, global companies, virtual biotechs and CROs. Today, Claire consults global health companies ranging from spin outs to multinational companies on how to fast track their technology to market. Claire has worked

en

44:06

Building robust and scalable systems

Molecule to Market: Inside the outsourcing space ·

2020/07/27

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kevin Orfan, President at Sharp. Kevin has been in the pharmaceutical and medical device industry for over 30 years and has incredible experience in the contract manufacturing space. He began his pharma career at Abbott Laboratories before moving to Hospira and then Pfizer CentreOne. He joined Sharp as president in 2019 and now oversees its global operations. Your host, Raman

en

28:49

Entrepreneurship in the life science space

Molecule to Market: Inside the outsourcing space ·

2020/07/22

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeffrey Kiplinger, Co-Founder of Cohere Business Strategies and advisor and coach for entrepreneurs in the life science space. Jeffrey Co-Founded Research Operations Group in 2000, founded Averica Discovery Services in 2007, and has over 35 academic publications and holds a PhD in organic chemistry. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply

en

43:53

Advocating for the CDMO sector

Molecule to Market: Inside the outsourcing space ·

2020/07/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gil Roth, Founder and President of the Pharma & Biopharma Outsourcing Association (PBOA). Previous to launching PBOA in 2014, Gil helped launch Contract Pharma in 1999 and served as the founding editor for 15 years. Contract Pharma has since grown to become one of the most respected magazines in the industry. Your host, Raman Sehgal, discusses the pharmaceutical and

en

25:19

The benefits of postponement packaging

Molecule to Market: Inside the outsourcing space ·

2020/07/15

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dexter Tjoa, CEO at Tjoapack. With a master's from Oxford University, Dexter joined Tjoapack about 5 years ago. His career has accelerated at an incredible speed since taking over the family business from his father, who founded Tjoapack over 30 years ago in the Netherlands. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guest Dexter Tjoa

en

33:53

Taking the family-owned CDMO global

Molecule to Market: Inside the outsourcing space ·

2020/07/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bobby Sheng, CEO and Chairman of Bora Pharmaceuticals. A California native and an experienced leader in the pharmaceutical industry, Bobby is skilled in international business, management, mergers & acquisitions, finance, and marketing. He graduated from University of California, Berkeley and now resides in Taiwan. Your host, Raman Sehgal, discusses the pharmaceutical and

en

38:12

The increasing demand for HPAPI

Molecule to Market: Inside the outsourcing space ·

2020/07/06

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with John Ross, President at Mayne Pharma US. John Ross has spent 15 years in the pharma contract services space in senior roles following some time at Eli Lilly and PWC. He joined Mayne in 2013 as a VP and transitioned to President in 2017. Today, he oversees over 550+ people in North Carolina and has managed a huge injection of investment in the business. Your host, Raman Sehgal,

en

35:12

A CDMO on the Covid-19 frontline

Molecule to Market: Inside the outsourcing space ·

2020/07/01

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Quirmbach, Group Chief Executive Officer and President at Corden Pharma. Michael has been in the contract services space for 20 years. He joined Corden Pharma in 2014, holding positions as Vice President, Marketing and Sales and Chief Business Officer before becoming CEO & President in 2019. Prior to joining Corden Pharma, he held positions of increasing responsibility at

en

248 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter